In this role, Heiko will be leveraging his extensive experience in strategic leadership, growing market share, and continuous improvement to achieve Heraeus Medevio’s vision of improving 100 million lives every year. Heiko joined Heraeus in 2000 and has since held numerous global R&D and business leadership roles. Most recently, as Chief Commercial Leader, he was in charge of Medevio’s Product and Portfolio Management, Sales and Marketing, which included responsibility for the overall business strategy.
“Heiko’s experience and success in so many areas of our business gives me every confidence he will lead Heraeus Medevio in continuing to achieve double-digit growth each year. Heiko is a great people leader who helped build our current strategy, and I know he is the right person to lead the company in its journey,” says Peter Reimer, former President of Heraeus Medevio.
Dr. Reimer is joining the Heraeus Holding and has been appointed Member of the Heraeus Group Management Committee (GMC) starting July 1st, 2023.
In his new role, Peter Reimer will help to develop Medical Technology companies to maximize value creation through means like ecosystem building and identification of M&A targets.
For Jan Rinnert, CEO and Chairman of the Board of Management of the Heraeus Group, the new appointments reflect the importance of the company’s healthcare businesses. “Our goals are two-fold: continue Heraeus Medevio’s outstanding growth and expand our broader market presence in healthcare. Peter’s success at Medevio makes him the perfect strategic leader to help our healthcare businesses grow and thrive. And throughout Heiko’s tenure, customers, employees and partners alike have gotten to know his unmatched commitment to med-tech innovation, excellence and, most importantly, better outcomes for patients.”
Heiko studied at the Friedrich Schiller University in Jena, Germany, and the Western Oregon University in Monmouth, Oregon, US. He holds a Master´s Degree in Physics.